iQure Pharma Inc.

CIK 1996977 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for iQure Pharma Inc..

Recent SEC filings

FiledFormAccession number
Jun 3, 2026D0001996977-26-000001
Nov 3, 2025D0001996977-25-000003
Jan 16, 2025D0001996977-25-000001
Apr 16, 2024D0001996977-24-000001
Oct 11, 2023D0001996977-23-000001